Cas:618382-83-5 2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid manufacturer & supplier

We serve Chemical Name:2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid CAS:618382-83-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid

Chemical Name:2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid
CAS.NO:618382-83-5
Synonyms:hms2740a20;hms1757f07
Molecular Formula:C14H9ClN2O2S
Molecular Weight:304.75100
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:529.9ºC at 760 mmHg
Density:1.47g/cm3
Index of Refraction:1.708
PSA:83.36000
Exact Mass:304.00700
LogP:3.95240

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like hms2740a20 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,hms1757f07 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hms1757f07 Use and application,hms2740a20 technical grade,usp/ep/jp grade.


Related News: If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid manufacturer If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid supplier An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. 2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid vendor If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 2-(3-chlorophenyl)-5-thiophen-2-ylpyrazole-3-carboxylic acid factory South Korea and Japan are barring noncitizens who traveled recently to Hubei, the province at the center of the outbreak.